AXIM Biotechnologies, Inc. (OTCMKTS:AXIM) Short Interest Up 538.0% in January

AXIM Biotechnologies, Inc. (OTCMKTS:AXIM) saw a significant increase in short interest in January. As of January 15th, there was short interest totalling 87,400 shares, an increase of 538.0% from the December 31st total of 13,700 shares. Based on an average trading volume of 1,432,000 shares, the days-to-cover ratio is currently 0.1 days.

AXIM Biotechnologies Stock Performance

OTCMKTS AXIM traded down $0.00 during trading on Friday, hitting $0.00. The company had a trading volume of 41,100 shares, compared to its average volume of 1,040,780. AXIM Biotechnologies has a one year low of $0.00 and a one year high of $0.02.

AXIM Biotechnologies Company Profile

AXIM Biotechnologies, Inc engages in the development and sale of diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and other diseases. The company is developing tests for dye eye diseases; SARS-CoV-2 neutralizing antibody tests; and fentanyl neutralizing antibody tests. It also developing a line of novel diagnostics for early cancer detection, response to treatment, and recurrence monitoring.